Abbott Laboratories (ABT) Surged Ahead of the Market in 2025 with Steady Earnings Momentum

By Yahoo! Finance   |   2 weeks ago
Abbott Laboratories (ABT) Surged Ahead of the Market in 2025 with Steady Earnings Momentum

In Q1 2025, despite challenges from tariffs, a medical device company exceeded Wall Street expectations in earnings and sales growth. CEO Ford highlighted solid growth in diagnostics business globally, except in China, aiming to explore other markets.

Read More

Did you find this insightful?